| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 3 Nov 2026 | 22 Oct 2026 |
| Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 inter alia to consider and approve Global Health Limited has informed the BSE that the meeting of the Board of Directors of the Company is scheduled to be held on 03/11/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter & Half Year ended September 30 2026. Outcome of Board Meeting held on November 03, 2026, to consider and approved the unaudited financial Results for the Quarter & Half year ended September 30, 2026. (As per BSE announcement dated on : 03.11.2026) | ||
| Board Meeting | 30 Jul 2026 | 20 Jul 2026 |
| Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended June 30 2026 Result for the Quarter ended June 30, 2026 (As Per BSE Announcement Dated on: 30/07/2026) | ||
| Board Meeting | 14 May 2026 | 6 May 2026 |
| Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve (a) the Audited Financial results of the Company for the quarter and year ended March 31, 2026; and (b) Consider and recommend final dividend, if any, on the Equity Shares of the Company subject to approval of Shareholders in Annual General Meeting. Outcome for Board Meeting held today for approving Audited Financials and Recommending Final Dividend. (As Per BSE Annoncement Dated on:14.05.2026) | ||
| Board Meeting | 27 Apr 2026 | 27 Apr 2026 |
| Intimation under Regulation 30 of SEBI Listing Regulations. | ||
| Board Meeting | 25 Mar 2026 | 25 Mar 2026 |
| Board Meeting Intimation under Regulation 30 of SEBI Listing Regulations held today i.e. March 25, 2026. | ||
| Board Meeting | 4 Feb 2026 | 24 Jan 2026 |
| Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve Unaudited Financial Results for Third quarter and Nine-Months ended December 31 2025. Outcome of Board Meeting held on February 04, 2026 to consider unaudited financial results for third Quarter and Nine-months ended December 31, 2025. Financial Results for Third Quarter and Nine Months ended on December 31, 2025. (As Per BSE Announcement Dated on:04.02.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
